Clinical Trials
2 trialsNCT01552434 2026-05-15
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00030043 2015-03-25
An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors
FDA Office of Orphan Products Development
Phase 1 Completed